Improving postsurgical paresis in brain tumor patients by transcranial magnetic stimulation

Journal of Neuro-Oncology – Recently, reduction of transcallosal inhibition by contralateral navigated repetitive transcranial magnetic stimulation (nrTMS) improved neurorehabilitation of glioma…

Read the full article here

Source: link.springer.com

Categories: Oncologists1, General Medicine News

Tags: JNO

Tweets with this article

Journal of Neuro-Oncology

Rosenstock et al. reported that navigated repetitive transcranial magnetic stimulation in brain tumor patients reduces transcallosal inhibition, with a notably low number needed to treat, particularly in cases caused by ischemia. #JNO Read more:https://t.co/OaVYxA4lI9 https://t.co/OEmlFIgIzY

Amneal Receives FDA Approval for Lenalidomide Capsules | Blood Cancers Today

Lenalidomide is indicated to treat myeloma in combination with dexamethasone and transfusion-dependent anemia due to myelodysplastic syndromes.

Blood Cancers Today February 23, 2025

FORTIFI-HN01 Trial Enrolls First Patients for Novel HNSCC Therapy

The FORTIFI-HN01 trial has begun enrolling patients with advanced head and neck cancer to evaluate ficerafusp alfa plus pembrolizumab as a first-line therapy.

Targeted Oncology February 23, 2025

CARGO Therapeutics to Discontinue Phase 2 Study of Firi-Cel in R/R LBCL

CARGO Therapeutics announced that it will discontinue the phase 2 FIRCE-1 trial evaluating firi-cel in relapsed/refractory large B-cell lymphoma.

OncLive.com February 23, 2025

ADC Anetumab Ravtansine Does Not Improve PFS vs Paclitaxel in High-Grade Serous Ovarian Cancer

Anetumab ravtansine plus bevacizumab failed to improve efficacy vs paclitaxel plus bevacizumab in platinum-resistant high-grade ovarian cancer.

OncLive.com February 23, 2025

Nab-Paclitaxel Plus SOC Chemo Fails to Improve OS in Newly Diagnosed Advanced Biliary Tract Cancer

Results from SWOG S1815 showed no survival benefit for nab-paclitaxel plus gemcitabine and cisplatin in advanced biliary tract cancer.

OncLive.com February 23, 2025

Firstborn Twins May Have Higher Risk of Leukemia

New research suggests that firstborn twins may have a greater risk of developing leukemia than second-born twins.

CancerTherapyAdvisor February 23, 2025

AACR Elections

The voting deadline for the AACR Election is February 27.

AACR February 23, 2025

Olaparib Elicits Improved OS Rates in Platinum-Sensitive, Germline/Somatic BRCA+ Relapsed Ovarian Cancer

A final analysis of the LIGHT trial showed olaparib demonstrated higher OS rates in patients with relapsed ovarian cancer who had germline or somatic BRCA…

OncLive.com February 23, 2025

FDA Approves Mirdametinib in Adult/Pediatric NF1-PN

Findings from the phase 2b ReNeu trial support the approval of mirdametinib for patients with neurofibromatosis type 1-associated plexiform neurofibromas.

Cancer Network February 23, 2025

Hyper-Elevated RNA Polymerase II May Point to Increased Tumor Aggressiveness

Directly measuring gene transcription activity from DNA reveals that hyper-elevated RNA Polymerase II levels are associated with tumor aggressiveness.

Fred Hutch February 23, 2025

Related Articles